⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 1, 2026

Ropivacainhydrochlorid Kabi 5 mg/ml Injektionslösung 5 mg/ml (Injektionslösung)

📷 Wikipedia: Ropivacaine · Source
Ropivacainhydrochlorid Kabi 5 mg/ml Injektionslösung 5 mg/ml (Injektionslösung)
📷 Wikipedia: Ropivacaine · Source
Ropivacaine hydrochloride Kabi 5 mg/ml injection solution 5 mg/ml (injection solution) is currently unavailable due to a manufacturing delay.
⚠️
Shortage ongoing
ROPIVACAINHYDROCHLORID MONOHYDRAT is currently in short supply in AT.
📈 Timeline
15 days active so far
June 3, 2026 June 17, 2026

What is this? This is a liquid medicine called ropivacaine. It is used to numb parts of the body before medical procedures.

What's happening? The medicine is not available right now. It will be back in stock on a future date.

Does this affect me? If you were prescribed this medicine, you may not be able to get it until it is back in stock.

What should I do? Ask your pharmacist or doctor for advice about other options while you wait.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ROPIVACAINHYDROCHLORID MONOHYDRAT
Agency-published detail

ATC: N01BB09 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Fresenius Kabi Austria GmbH, Hafnerstraße 36, 8055 Graz, Österreich · Affected packs: 5 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-05-28, resupply 2026-08-14]

First published
June 1, 2026
Last refreshed by us
10 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Ropivacainhydrochlorid Kabi 5 mg/ml Injektionslösung 5 mg/ml (Injektionslösung). Ropivacaine hydrochloride Kabi 5 mg/ml injection solution 5 mg/ml (injection solution) is currently unavailable due to a manufacturing delay.
▸ When was this alert issued?
This alert was issued on June 1, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.